IAGG World Congress, July 23-26


Industry-Supported Symposia

  • Expanding Perspectives on Vaccine-Preventable Disease in Older Adult Populations
    Pfizer, Inc.
  • Emergent Issues in Pneumococcal Disease Among Aging Populations
    Pfizer, Inc.

Innovation Theater

  • Influenza in Older Adults—A Vulnerable Population
    Stefan Gravenstein, Janet E. McElhaney



  • Session 575
    • Antibody Responses to 23-Valent Pneumococcal Polysaccharide Vaccine After Primary and Revaccination
      Kenji Kawakami, Hiroyuki Kishino, Shinichi Kanazu, Nobuhito Toshimuzu, Ruroiko Yokokawa, Kenichi Takahashi, Mel Kohn, Luwey Musey
    • Responses to 23-Valent Pnuemococcal Polysaccharide Vaccine in Adults 70-79 With Chronic Diseases
      Kenji Kawakami, Hiroyuki Kishino, Shinichi Kanazu, Nobuhito Toshimuzu, Ruroiko Yokokawa, Kenichi Takahashi, Mel Kohn, Luwey Musey
    • The Need for Better Vaccines for Older Adults
      William Schaffner, Stefan Gravenstein
    • Zoster Vaccine Live: Review of Postmarketing Safety by Decade of Life
      English Willis, Meredith Woodward, Elizabeth Brown, Zoran Popmihajlov
    • Effectiveness of Live Zoster Vaccine in Preventing Postherpetic Neuralgia (PHN)
      Roger Baxter, Joan Bartlett, Bruce Fireman, Morgan Marks, John Hansen, Laurie Aukes, Eddy Bresnitz, Patricia Saddier
    • Disparities in Influenza Immunization Status Among Post-Acute and Long-Term Care Patients/Residents
      Colene Byrne, Lauren Palmer, Daniel Barch, Nicole Jarrett, Amy Helburn, Holly Neumann, Laura Smith
    • Immune Risk Profile (IRP) and Morbidity Phenotype of Independent Oldest Old
      Marcelo Caldeira, Milena Brunialti, Reinaldo Salomão, Clineu Mello, Almada Filho, Maysa Cendoroglo
  • Session 900
    • Using Educational Interventions to Affect Provider Practices in Immunizations
      Debra Hawks
    • UN Agenda 2030: Adult Vaccinations as a Public Health Interest for Healthy Ageing
      Cynthia Stuen, Jane Barratt, Ken Bluestone, Erica Dhar
  • Session LB910
    • Impact on Cardiorespiratory Outcomes of High vs Standard Dose Influenza Vaccine in U.S. Nursing Homes
      Stefan Gravenstein, Jessica Ogarek, Monica Taljaard, Lisa Han, H. Edward Davidson, Pedro Gozalo, Vincent Mor
    • Influenza-Induced Muscle Degradation: A Pathway to Age-Associated Disability
      Jenna Bartley, Spencer Keilich, George Kuchel, Laura Haynes
    • Production of TNF Ex Vivo Is Predictive of an Immune Response to Flu Vaccination in Elderly Subjects
    • Frederic Bloch, Benedicte Charmeteau, Michael Tovey, Jean-François Meritet, Corinne Desaint, Odile Launay, Pierre Lebon

  • Session LB3720
    • Cost of Diagnosed Herpes Zoster Complications in Patients Age ≥50 Years: A U.S. Claims Data Analysis
      Debora Rausch, Myron Levin, Juliana Meyers, Sean Candrilli, Songkai Yan, Girishanthy Krishnarajah, Brandon Patterson
  • Session LB4585
    • Rotavirus Vaccination of Infants May Reduce Acute Gastroenteritis Rates in the Elderly in England
      Thomas Verstraeten, Tom Cattaert, Margarita Riera